JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency
Previous work suggested that histone demethylase JMJD3 is detrimental to somatic cell reprogramming. Here, the authors show that while JMJD3 has a context-independent detrimental effect on early stages of reprogramming, during late stages it activates epithelial and pluripotency genes together with...
Guardado en:
Autores principales: | Yinghua Huang, Hui Zhang, Lulu Wang, Chuanqing Tang, Xiaogan Qin, Xinyu Wu, Meifang Pan, Yujia Tang, Zhongzhou Yang, Isaac A. Babarinde, Runxia Lin, Guanyu Ji, Yiwei Lai, Xueting Xu, Jianbin Su, Xue Wen, Takashi Satoh, Tanveer Ahmed, Vikas Malik, Carl Ward, Giacomo Volpe, Lin Guo, Jinlong Chen, Li Sun, Yingying Li, Xiaofen Huang, Xichen Bao, Fei Gao, Baohua Liu, Hui Zheng, Ralf Jauch, Liangxue Lai, Guangjin Pan, Jiekai Chen, Giuseppe Testa, Shizuo Akira, Jifan Hu, Duanqing Pei, Andrew P. Hutchins, Miguel A. Esteban, Baoming Qin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac78b96cad84437384cee675241f1bdb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
JMJD3 and UTX determine fidelity and lineage specification of human neural progenitor cells
por: Yongli Shan, et al.
Publicado: (2020) -
JMJD6 regulates ERα methylation on arginine.
por: Coralie Poulard, et al.
Publicado: (2014) -
JMJD5 is a human arginyl C-3 hydroxylase
por: Sarah E. Wilkins, et al.
Publicado: (2018) -
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma
por: Matthew Wong, et al.
Publicado: (2019) -
BMI1 enables interspecies chimerism with human pluripotent stem cells
por: Ke Huang, et al.
Publicado: (2018)